three
revers
transcript
recombinas
polymeras
amplif
assay
later
flow
dipstick
rtrpalfd
develop
identif
matrix
hemagglutinin
ha
gene
detect
influenza
viru
distinguish
subtyp
assess
assay
specif
show
crossreact
target
limit
detect
copi
per
reaction
matrix
gene
copi
per
reaction
ha
gene
copiesreact
ha
gene
sampl
test
rtrpalfd
assay
posit
influenza
viru
posit
posit
compar
result
obtain
realtim
rtpcr
assay
sensit
rtrpalfd
assay
matrix
specif
sensit
rtrpalfd
assay
lower
realtim
rtpcr
compar
better
convent
rtpcr
much
better
ridt
conclus
assay
offer
effici
reliabl
tool
identif
subtyp
influenza
viru
subtyp
resourcelimit
set
influenza
virus
common
major
pathogen
caus
viral
respiratori
infect
virus
seriou
threat
health
peopl
worldwid
sever
morbid
mortal
caus
accord
world
health
organ
season
influenza
virus
caus
death
year
influenza
virus
belong
orthomyxovirida
famili
divid
four
type
type
b
c
influenza
viru
iav
virul
pathogen
base
two
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
iav
divid
mani
subtyp
also
known
serotyp
far
serotyp
ha
serotyp
na
describ
verifi
due
reassort
mutat
iav
subtyp
evolv
constantli
caus
pandem
recent
exampl
influenza
viru
among
iav
subtyp
common
subtyp
caus
diseas
human
around
world
although
vaccin
effect
countermeasur
infect
influenza
viru
limit
still
exist
clinic
na
inhibitor
adamantan
approv
treatment
prevent
influenza
viru
infect
howev
subtyp
highlevel
antivir
resist
current
circul
resist
adamantan
na
inhibitor
moreov
effect
antivir
treatment
need
initi
within
h
ill
onset
henc
necessari
rapidli
identifi
iav
accur
treatment
infect
control
infect
iav
clinic
identifi
diagnos
base
patient
sign
symptom
howev
approxim
individu
infect
asymptomat
other
infect
bacteria
virus
respiratori
syncyti
viru
parainfluenza
viru
rhinoviru
also
show
influenzalik
sign
symptom
compar
laboratori
diagnost
technolog
clinic
diagnosi
estim
posit
predict
valu
laboratori
long
turnaround
time
viral
cultur
unfavor
accur
treatment
control
iav
rapid
influenza
diagnost
test
ridt
wide
use
identifi
iav
healthcar
servic
simpl
swift
defect
inconsist
sensit
recent
nucleic
acid
amplif
test
naat
revers
transcript
polymeras
chain
reaction
rtpcr
realtim
rtpcr
revers
transcript
loopmedi
isotherm
amplif
rtlamp
use
rapid
sensit
diagnosi
subtyp
iav
nevertheless
method
requir
expens
equip
andor
skill
technician
make
inappropri
use
develop
countri
recombinas
polymeras
amplif
rpa
lowresourc
diagnost
tool
depend
sever
enzym
run
constant
temperatur
previous
rpa
use
diagnosi
mani
pathogen
human
immunodefici
viru
type
dengu
viru
brucella
great
success
therefor
detect
iav
differenti
subtyp
could
achiev
rtrpa
later
flow
dipstick
provid
effici
rapid
assay
clinic
diagnosi
epidemiolog
survey
studi
develop
three
revers
transcriptionrpa
assay
later
flow
dipstick
rtrpalfd
detect
iav
distinguish
subtyp
one
assay
target
matrix
gene
use
diagnosi
iav
iavposit
sampl
subtyp
use
two
assay
eightyseven
throat
swab
collect
children
influenzalik
ill
jinl
hospit
nanj
jiangsu
china
use
virocult
swab
yocon
biotech
co
beij
china
store
within
h
specimen
collect
februari
march
respiratori
pathogen
use
studi
list
tabl
clinic
isol
includ
influenza
b
viru
flu
b
respiratori
syncyti
viru
rsv
subgroup
b
previous
identifi
rtpcr
sequenc
influenza
b
viru
design
respect
two
subtyp
iav
strain
ahong
provid
shanghai
institut
biolog
product
co
ltd
staphylococcu
aureu
atcc
haemophilu
influenza
atcc
streptococcu
pneumonia
atcc
streptococcu
hemolyticu
chlamydia
pneumonia
mycoplasma
pneumonia
store
laboratori
human
metapneumoviru
hmpv
herp
simplex
viru
human
coronaviru
human
adenoviru
hadv
parainfluenza
viru
human
rhinoviru
hrv
twentyfour
viral
rna
extract
nasopharyng
aspir
suppli
ningbo
health
biom
co
ltd
ningbo
zhejiang
china
studi
approv
human
use
ethic
committe
jinl
hospit
inform
consent
obtain
patient
guardian
sinc
matrix
gene
conserv
usual
use
detect
iav
previou
report
primer
nfo
escherichia
coli
endonucleas
iv
probe
design
matrix
gene
use
detect
iav
also
primer
probe
design
subtyp
due
antigen
drift
genet
variabl
iav
mani
isol
collect
identifi
influenza
surveil
annual
make
difficult
align
publish
sequenc
iav
consequ
firstli
classifi
sequenc
databas
base
geograph
countryregion
collect
date
releas
date
influenza
viru
resourc
http
wwwncbinlmnihgov
genomesfludatabasenphselectcgi
mainform
secondli
consensu
sequenc
obtain
align
sequenc
isol
countri
within
fiveyear
span
final
consensu
sequenc
align
use
clustalw
http
wwwebiac
uktoolsmsaclustalo
primer
nfo
probe
design
accord
conserv
sequenc
synthes
sangon
biotech
shanghai
china
shown
tabl
tabl
nfo
probe
modifi
fluorescein
isothiocyan
fitc
end
intern
abas
nucleotid
analogu
tetrahydrofuran
thf
extens
block
group
oppos
nfo
probe
primer
label
biotin
end
viral
nucleic
acid
extract
viral
transport
medium
elut
elut
buffer
use
tianamp
viru
dnarna
kit
tiangen
biotech
co
ltd
beij
china
recommend
manufactur
complementari
dna
cdna
synthes
use
revers
transcript
system
promega
madison
wi
usa
briefli
ml
tube
rna
mgcl
mm
revers
transcript
buffer
dntp
mixtur
mm
recombin
rnasin
ribonucleas
inhibitor
random
primer
amv
revers
transcriptas
mix
total
volum
increas
ad
nucleasefre
water
mixtur
incub
min
room
temperatur
subsequ
min
pcr
perform
use
ex
taq
version
plu
dye
kit
takara
dalian
china
total
volum
contain
cdna
premix
taq
forward
primer
ampb
revers
primer
ampc
amplif
cycl
perform
follow
min
cycl
cycl
min
pcr
product
directli
analyz
gel
electrophoresi
agaros
gel
realtim
pcr
perform
appli
biosystem
realtim
pcr
system
thermo
scientif
waltham
usa
use
premix
ex
probe
qpcr
kit
takara
dalian
china
primer
taqman
probe
use
qpcr
report
inform
molecular
detect
influenza
virusesupd
tabl
ml
tube
cdna
premix
ex
taq
forward
revers
primer
taqman
probe
rox
refer
dye
ii
nucleasefre
water
ad
vortex
mix
reaction
run
follow
min
cycl
ct
valu
defin
quantif
cycl
repres
cross
point
fluoresc
valu
threshold
calcul
automat
softwar
appli
biosystem
foster
citi
ca
usa
posit
sampl
defin
ct
valu
less
sampl
ct
valu
confirm
forward
primer
promot
terminu
use
amplifi
target
gene
matrix
ha
ha
pcr
gel
purif
linear
product
bear
promot
blunt
dna
polymeras
transcrib
use
vitro
transcript
kit
takara
dalian
china
digest
use
dnase
min
final
singlestrand
rna
purifi
use
phenolchloroform
extract
concentr
measur
nanodrop
spectrophotomet
thermo
scientif
waltham
usa
lfd
prepar
accord
previou
report
compos
sampl
pad
conjug
pad
nitrocellulos
membran
absorb
pad
plastic
adhes
back
streptavidinco
gold
colloid
dispens
onto
conjug
pad
dri
overnight
antifitc
antibodi
test
line
abcam
cambridg
usa
biotinyl
bovin
serum
albumin
control
line
nanj
runyan
biotechnolog
co
ltd
china
stripe
onto
nitrocellulos
membran
dri
h
final
lfd
assembl
cut
width
strip
use
microcomput
automat
cut
machin
shanghai
goldbio
co
ltd
china
rpa
perform
total
volum
use
twistdx
nfo
kit
twistdx
cambridg
uk
reaction
rehydr
buffer
forward
revers
primer
nfo
probe
cdna
nucleasefre
water
mix
final
mm
magnesium
acet
ad
mixtur
incub
min
rpa
product
analyz
use
lfd
five
microlit
rpa
product
ad
tube
contain
phosphatebuff
salin
pbst
mm
nacl
mm
kcl
mm
na
hpo
mm
kh
po
ph
lfd
insert
tube
incub
min
imag
record
use
smartphon
analyz
use
imagej
softwar
nation
institut
health
md
usa
imag
convert
greyscal
subsequ
mean
optic
densiti
fix
area
determin
rel
optic
densiti
calcul
divid
mean
optic
densiti
maximum
grey
valu
sampl
defin
posit
rel
optic
densiti
greater
threshold
calcul
averag
twenti
neg
sampl
plu
three
time
standard
deviat
experiment
data
analyz
spss
statist
spssinc
chicago
usa
signific
level
set
diagnost
perform
rtrpalfd
assay
evalu
comparison
realtim
rtpcr
clinic
sensit
specif
calcul
use
standard
formula
clinic
test
result
obtain
rtrpalfd
realtim
rtpcr
analyz
mcnemar
test
optim
perform
detect
subtyp
iav
design
synthes
eight
set
primer
probe
tabl
viral
rna
extract
two
clinic
isol
detect
rtrpalfd
assay
result
indic
matrix
show
best
perform
fig
iav
subtyp
influenza
b
viru
flu
b
respiratori
pathogen
use
evalu
specif
three
rtrpalfd
assay
tabl
fig
shown
fig
clear
band
emerg
test
line
detect
matrix
rtrpalfd
assay
visibl
band
present
test
line
detect
respiratori
pathogen
posit
result
obtain
detect
either
indic
two
assay
specif
crossreact
pathogen
two
subtyp
fig
although
posit
neg
result
visibl
nake
eye
result
rtrpalfd
quantit
analyz
use
imag
softwar
diminish
influenc
subject
factor
fig
determin
detect
limit
rtrpalfd
assay
rna
transcript
matrix
dilut
nucleasefre
water
test
tabl
fig
fig
calcul
copi
number
transcrib
rna
rpa
reaction
probit
analysi
indic
rtrpalfd
assay
probabl
abl
detect
copi
tabl
fig
sensit
rtrpalfd
assay
lower
realtim
rtpcr
compar
better
convent
rtpcr
much
better
ridt
eightyseven
throat
swab
specimen
twentyfour
nucleic
acid
test
use
rtrpalfd
assay
realtim
rtpcr
assay
tabl
tabl
compar
realtim
rtpcr
assay
refer
method
diagnost
paramet
rtrpalfd
assay
includ
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
calcul
shown
tabl
overal
twentyseven
sampl
posit
iav
matrix
rtrpalfd
assay
thirtysix
sampl
posit
matrix
realtim
rtpcr
found
ct
valu
nine
discord
sampl
greater
fourteen
sampl
rtrpalfd
fifteen
sampl
posit
realtim
rtpcr
one
sampl
ct
valu
neg
rtrpalfd
assay
addit
four
fourteen
sampl
confirm
realtim
rtpcr
neg
rtrpalfd
assay
ct
valu
four
discord
sampl
greater
mcnemar
test
indic
differ
rtrpalfd
realtim
rtpcr
distinguish
subtyp
signific
p
detect
iav
p
agreement
rtrpalfd
realtim
rtpcr
evalu
kappa
test
correl
kappa
valu
matrix
demonstr
assay
good
agreement
detect
iav
subtyp
order
comprehens
evalu
perform
rtrpalfd
posit
throat
swab
specimen
matrix
realtim
rtpcr
test
ridt
rapid
influenza
viru
antigen
test
kit
guangzhou
wondfo
biotechnolog
co
ltd
china
although
commerci
antigen
test
kit
rapid
fourteen
sampl
posit
iav
tabl
tabl
posit
rate
much
lower
matrix
rtrpalfd
assay
mcnemar
test
suggest
signific
differ
matrix
rtrpalfd
ridt
p
matrix
rtrpalfd
assay
could
sensit
use
diagnosi
iav
comparison
ridt
studi
develop
three
rtrpalfd
assay
detect
subtyp
iav
target
three
assay
matrix
ha
ha
gene
matrix
gene
consid
conserv
among
iav
select
identif
iav
primer
nfo
probe
design
accord
align
matrix
gene
sequenc
past
sever
decad
subtyp
circul
worldwid
accord
latest
influenza
surveil
account
major
circul
virus
therefor
design
anoth
two
assay
subtyp
thu
provid
rapid
conveni
method
subtyp
specif
rtrpalfd
assay
indic
expect
signal
gener
test
line
crossreact
observ
sensit
rtrpalfd
assay
evalu
use
singlestrand
rna
transcript
matrix
gene
limit
detect
determin
copi
per
reaction
respect
clinic
sampl
use
evalu
perform
rtrpalfd
assay
compar
perform
realtim
rtpcr
total
sampl
test
although
sensit
rtrpalfd
assay
slightli
wors
realtim
rtpcr
former
better
choic
pointofcar
test
resourcelimit
set
ridt
wide
use
screen
influenza
viru
offici
clinic
primari
healthcar
servic
howev
detect
limit
ridt
time
higher
realtim
rtpcr
induc
falseneg
result
result
inappropri
antibiot
use
treatment
failur
patient
viral
spread
neg
result
ridt
rule
influenza
infect
particularli
season
high
influenza
activ
neg
result
ridt
inconsist
clinic
sign
symptom
rtrpalfd
assay
use
effect
supplement
iav
diagnosi
addit
rtrpalfd
assay
use
identifi
subtyp
iav
epidemiolog
investig
although
rel
rapid
specif
sensit
diagnosi
iav
subtyp
rtrpalfd
assay
two
major
drawback
assay
one
revers
transcript
rpa
two
separ
reaction
simplifi
process
onestep
rtrpa
perform
singl
tube
contain
twistdx
nfo
kit
twistdx
cambridg
uk
revers
transcriptas
xl
amv
takara
dalian
china
rnase
inhibitor
takara
dalian
china
use
detect
iav
discrimin
compar
twostep
rtrpa
perform
onestep
rtrpa
unsatisfactori
probabl
exist
inhibitori
effect
biotinlabel
revers
primer
revers
transcriptas
rt
rpa
need
tri
differ
strategi
make
rt
rpa
harmoni
run
singl
tube
exist
potenti
amplicon
contamin
rpa
product
pipet
lfd
analysi
open
reaction
tube
caus
amplicon
contamin
promin
concern
qualiti
control
assay
especi
use
small
hospit
rural
area
untrain
staff
previou
studi
indic
uracilnglycosylas
ung
dutp
effect
elimin
amplicon
contamin
pcr
lamp
possibl
elimin
rpa
amplicon
contamin
use
ung
dutp
importantli
mani
seal
devic
develop
analysi
rpa
product
also
avoid
amplicon
contamin
therefor
combin
rpa
ung
dutp
andor
seal
lf
devic
reduc
amplicon
contamin
perform
futur
cost
test
per
sampl
approxim
rt
rpa
reaction
lfd
reaction
system
lfd
assembl
greatli
reduc
cost
test
improv
avail
throughput
cost
rtrpalfd
decreas
exampl
multiplex
recombinas
polymeras
amplif
assay
develop
detect
intestin
protozoa
reduc
cost
later
flow
strip
furthermor
use
lfd
effect
save
cost
fluoresc
detector
overal
rtrpalfd
assay
develop
studi
advantag
detect
subtyp
iav
suitabl
lowresourc
set
perform
rel
low
temperatur
requir
expens
instrument
moreov
sensit
specif
enough
routin
clinic
diagnosi
epidemiolog
investig
conclus
rtrpalfd
assay
describ
detect
subtyp
iav
offer
rel
rapid
sensit
specif
assay
diagnosi
iav
subtyp
procedur
perform
studi
involv
human
particip
accord
ethic
standard
jinl
hospit
china
helsinki
declar
later
amend
compar
ethic
standard
author
declar
conflict
interest
